Gascón-Irún et al: <strong>Gene</strong> therapy antiproliferative strategies against cardiovascular diseasemuscle cells by c-myc antisense oligomers. Circulation 90,I-147.Shi, Y, Fard, A, Galeo, A, Hutchinson, HG, Vermani, P, Dodge,GR, Hall, DJ, Shaheen, F, and Zalewski, A (1994b).Transcatheter delivery of c-myc antisense oligomers reducesneointimal formation in a porcine model of coronary arteryballoon injury. Circulation 90, 944-951.Shi, Y, Hutchinson, HG, Hall, DJ, and Zalewski, A (1993).Downregulation of c-myc expression by antisenseoligonucleotides inhibits proliferation of human smoothmuscle cells. Circulation 88, 1190-1195.Simon, MC (1995). Gotta have GATA. Nat <strong>Gene</strong>tics 11, 9-11.Simons, M, Edelman, ER, DeKeyser, J-L, Langer, R, andRosenberg, RD (1992). Antisense c-myb oligonucleotidesinhibit intimal arterial smooth muscle cell accumulation invivo. Nature 359, 67-70.Simons, M, and Rosenberg, RD (1992). Antisense nonmusclemyosin heavy chain and c-myb oligonucleotides supresssmooth muscle cell proliferation in vitro. Circ Res 70, 835-843.Smith, RC, Branellec, D, Gorski, DH, Guo, K, Perlman, H,Dedieu, J-F, Pastore, C, Mahfoudi, A, Denèfle, P, Isner, JM,and Walsh, K (1997a). p21 CIP1 -mediated inhibition of cellproliferation by overexpression of the Gax homeodomaingene. <strong>Gene</strong>s Dev 11, 1674-1689.Smith, RC, Wills, KN, Antelman, D, Perlman, H, Truong, LN,Krasinski, K, and Walsh, K (1997b). Adenoviral constructsencoding phosphorylation-competent full-length andtruncated forms of the human retinoblastoma protein inhibitmyocyte proliferation and neointima formation. Circulation96, 1899-1905.Speir, E, Modali, R, and Huang, E-S (1994). Potential role ofhuman cytomegalovirus and p53 interaction in coronaryrestenosis. Science 265, 391-394.Spraragen, SC, Bond, VP, and Dahl, LK (1962). Role ofhyperplasia in vascular lesions of cholesterol-fed rabbitsstudied with thymidine-3H autoradiography. Circ Res 11,329-336.Steinberg, D (2002). Atherogenesis in perspective:hypercholesterolemia and inflammation as partners in crime.Nat Med 8, 1211-1217.Stevaux, O, and Dyson, NJ (2002). A revised picture of the E2Ftranscriptional network and RB function. Curr Opin CellBiol 14, 684-691.Su, JZ, Fukuda, N, Hu, WY, and Kanmatsuse, K (2000).Ribozyme to human TGF-beta1 mRNA inhibits theproliferation of human vascular smooth muscle cells.Biochem Biophys Res Commun 278, 401-407.Suzuki, E, Evans, T, Lowry, J, Truong, L, Bell, DW, Testa, JR,and Walsh, K (1996). The human GATA-6 gene: structure,chromosomal location and regulation of expression by tissuespecificand mitogen-responsive signals. Genomics 38, 283-290.Suzuki, J-I, Isobe, M, Morishita, R, Aoki, M, Horie, S, Okubo,Y, Kaneda, Y, Sawa, Y, Matsuda, H, Ogihara, T, andSekiguchi, M (1997). Prevention of graft coronaryarteriosclerosis by antisense cdk2 kinase oligonucleotide.Nat Med 3, 900-903.Sylvester, AM, Chen, D, Krasinski, K, and Andrés, V (1998).Role of c-fos and E2F in the induction of cyclin Atranscription and vascular smooth muscle cell proliferation. JClin Invest 101, 940-948.Tanaka, K, Zou, JP, Takeda, K, Ferrans, VJ, Sandford, GR,Johnson, TM, Finkel, T, and Epstein, SE (1999). Effects ofhuman cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells.Circulation 99, 1656-1659.Tanner, FC, Boehm, M, Akyürek, LM, San, H, Yang, Z-Y,Tashiro, J, Nabel, GJ, and Nabel, EG (2000). Differentialeffects of the cyclin-dependent kinase inhibitors p27 Kip1 ,p21 Cip1 , and p16 Ink4 on vascular smooth muscle cellproliferation. Circulation 101, 2022-2025.Tanner, FC, Yang, Z-Y, Duckers, E, Gordon, D, Nabel, GJ, andNabel, EG (1998). Expression of cyclin-dependent kinaseinhibitors in vascular disease. Circ Res 82, 396-403.Ueno, H, Masuda, S, SNishio, S, Li, JJ, Yamamoto, H, andTakeshita, A (1997a). Adenovirus-mediated transfer ofcyclin-dependent kinase inhibitor p21 suppresses neointimalformation in the balloon-injured rat carotid arteries in vivo.Ann N Y Acad Sci 811, 401-411.Ueno, H, Yamamoto, H, Ito, S-i, Li, J-J, and Takeshita, A(1997b). Adenovirus-mediated transfer of a dominantnegativeH-ras suppresses neointimal formation in ballooninjuredarteries in vivo. Arterioscler Thromb Vasc Biol 17,898-904.van Vlijmen, BJ, Gerritsen, G, Franken, AL, Boesten, LS,Kockx, MM, Gijbels, MJ, Vierboom, MP, van Eck, M, vanDe Water, B, van Berkel, TJ, and Havekes, LM (2001).Macrophage p53 deficiency leads to enhancedatherosclerosis in APOE*3- Leiden transgenic mice. CircRes 88, 780-786.Veinot, JP, Ma, X, Jelley, J, and O'Brien, ER (1998). Preliminaryclinical experience with the pullback atherectomy catheterand the study of proliferation in coronary plaques. Can JCardiol 14, 1457-1463.Villa, AE, Guzman, LA, Poptic, EJ, Labhasetwar, V, D'Souza, S,Farrell, CL, Plow, EF, Levy, RJ, DiCorleto, PE, and Topol,EJ (1995). Effects of antisense c-myb oligonucleotides onvascular smooth muscle cell proliferation and response tovessel wall injury. Circ Res 76, 505-513.Wang, W, Chen, HJ, Schwartz, A, Cannon, PJ, Stein, CA, andRabbani, LE (1996). Sequence-independent inhibition of invitro vascular smooth muscle cell proliferation, migration,and in vivo neointimal formation by phosphorothioateoligodeoxynucleotides. J Clin Invest 98, 443-450.Wei, GL, Krasinski, K, Kearney, M, Isner, JM, Walsh, K, andAndrés, V (1997). Temporally and spatially coordinatedexpression of cell cycle regulatory factors after angioplasty.Circ Res 80, 418-426.Weir, L, Chen, D, Pastore, C, Isner, JM, and Walsh, K (1995).Expression of GAX, a growth-arrest homeobox gene, israpidly down-regulated in the rat carotid artery during theproliferative response to balloon injury. J Biol Chem 270,5457-5461.Winston, JT, Coats, SR, Wang, Y-Z, and Pledger, WJ (1996).Regulation of the cell cycle machinery by oncogenic ras.Oncogene 12, 127-134.Yamamoto, K, Morishita, R, Tomita, N, Shimozato, T,Nakagami, H, Kikuchi, A, Aoki, M, Higaki, J, Kaneda, Y,and Ogihara, T (2000). Ribozyme oligonucleotides againsttransforming growth factor-beta inhibited neointimalformation after vascular injury in rat model: potentialapplication of ribozyme strategy to treat cardiovasculardisease. Circulation 102, 1308-1314.Yang, Z, Oemar, BS, Carrel, T, Kipfer, B, Julmy, F, and Lüscher,TF (1998). Different proliferative properties of smoothmuscle cells of human arterial and venous bypass vessels:role of PDGF receptors, mitogen-activated protein kinase,and cyclin-dependent kinase inhibitors. Circulation 97, 181-187.Yang, Z-Y, Simari, RD, Perkins, ND, San, H, Gordon, D, Nabel,GJ, and Nabel, EG (1996). Role of p21 cyclin-dependentkinase inhibitor in limiting intimal cell proliferation inresponse to arterial injury. Proc Natl Acad Sci USA 93,7905-7910.88
<strong>Gene</strong> <strong>Therapy</strong> and <strong>Molecular</strong> <strong>Biology</strong> Vol 7, page 89Yonemitsu, Y, Kaneda, Y, Tanaka, S, Nakashima, Y, Komori, K,Sugimachi, K, and Sueishi, K (1998). Transfer of wild-typep53 gene effectively inhibits vascular smooth muscle cellproliferation in vitro and in vivo. Circ Res 82, 147-156.Zhou, YF, Leon, MB, Waclawiw, MA, Popma, JJ, Yu, ZX,Finkel, T, and Epstein, SE (1996). Association between priorcytomegalovirus infection and the risk of restenosis aftercoronary atherectomy. N Engl J Med 335, 624-630.Zhou, YF, Yu, ZX, Wanishsawad, C, Shou, M, and Epstein, SE(1999). The immediate early gene products of humancytomegalovirus increase vascular smooth muscle cellmigration, proliferation, and expression of PDGF betareceptor.Biochem Biophys Res Commun 256, 608-613.Zhu, NL, Wu, L, Liu, PX, Gordon, EM, Anderson, WF, Starnes,VA, and Hall, FL (1997). Downregulation of cyclin G1expression by retrovirus-mediated antisense gene transferinhibits vascular smooth muscle cell proliferation andneointima formation. Circulation 96, 628-635.Zou, X, Rudchenko, S, Wong, K-k, and Calame, K (1997).Induction of c-myc transcription by the v-Abl tyrosine kinaserequires Ras, Raf1, and cyclin-dependent kinases. <strong>Gene</strong>sDev 11, 654-662.Zou, Y, Hu, Y, Metzler, B, and Xu, Q (1998). Signaltransduction in arteriosclerosis: mechanical stress-activatedMAP kinases in vascular smooth muscle cells (review). Int JMol Med 1, 827-834.89
Change language